Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 45, 2010 - Issue 12
Submit an article Journal homepage
99
Views
11
CrossRef citations to date
0
Altmetric
Liver and Biliary Tract

Prolongation of interferon therapy for recurrent hepatitis C after living donor liver transplantation: Analysis of predictive factors of sustained virological response, including amino acid sequence of the core and NS5A regions of hepatitis C virus

Tomokazu Kawaoka Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
,
Nobuhiko Hiraga Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
,
Shoichi Takahashi Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, JapanCorrespondence[email protected]
,
Shintaro Takaki Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
,
Fukiko Mitsui Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
,
Masataka Tsuge Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
,
Yuko Nagaoki Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
,
Yuki Kimura Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
,
Yoshimasa Hashimoto Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
,
Yoshio Katamura Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
,
Akira Hiramatsu Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
,
Koji Waki Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
,
Michio Imamura Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
,
Yoshiiku Kawakami Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
,
Hiroshi Aikata Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
,
Hirotaka Tashiro Department of Surgery, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
,
Hideki Ohdan Department of Surgery, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
&
Kazuaki Chayama Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan
 show all
Pages 1488-1496 | Received 26 Apr 2010, Accepted 26 Jun 2010, Published online: 22 Jul 2010

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Rolf Hultcrantz. (2010) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 45:12, pages 1395-1396.
Read now

Articles from other publishers (10)

Tomokazu Kawaoka, Michio Imamura, Kei Morio, Yuki Nakamura, Masataka Tsuge, C. Nelson Hayes, Yoshiiku Kawakami, Hiroshi Aikata, Hidenori Ochi, Kouhei Ishiyama, Kentaro Ide, Hirotaka Tashiro, Hideki Ohdan & Kazuaki Chayama. (2016) Three patients treated with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation: Case report. Hepatology Research 46:7, pages 707-712.
Crossref
T. Kawaoka, M. Imamura, H. Kan, H. Fujino, T. Fukuhara, T. Kobayashi, Y. Honda, N. Naeshiro, A. Hiramatsu, M. Tsuge, C.N. Hayes, Y. Kawakami, H. Aikata, H. Ochi, K. Ishiyama, H. Tashiro, H. Ohdan & K. Chayama. (2015) Two Patients Treated With Simeprevir Plus Pegylated-Interferon and Ribavirin Triple Therapy for Recurrent Hepatitis C After Living Donor Liver Transplantation: Case Report. Transplantation Proceedings 47:3, pages 809-814.
Crossref
Tomokazu Kawaoka, Shoichi Takahashi, Yumiko Tatsukawa, Akira Hiramatsu, Nobuhiko Hiraga, Daiki Miki, Masataka Tsuge, Michio Imamura, Yoshiiku Kawakami, Hiroshi Aikata, Hidenori Ochi, Kouhei Ishiyama, Kentaro Ide, Hirotaka Tashiro, Hideki Ohdan & Kazuaki Chayama. (2014) Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation. Hepatology Research 44:12, pages 1259-1264.
Crossref
J. Howell, P. Angus & P. Gow. (2014) Hepatitis C recurrence: the Achilles heel of liver transplantation. Transplant Infectious Disease 16:1, pages 1-16.
Crossref
Nobuhisa Akamatsu & Yasuhiko Sugawara. (2013) Living-Donor Liver Transplantation and Hepatitis C. HPB Surgery 2013, pages 1-13.
Crossref
Tomokazu Kawaoka, Shoichi Takahashi, Shintaro Takaki, Akira Hiramatsu, Koji Waki, Nobuhiko Hiraga, Daiki Miki, Masataka Tsuge, Michio Imamura, Yoshiiku Kawakami, Hiroshi Aikata, Hidenori Ochi, Takashi Onoe, Hirotaka Tashiro, Hideki Ohdan & Kazuaki Chayama. (2012) Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation. Journal of Gastroenterology and Hepatology 27:9, pages 1467-1472.
Crossref
Tomokazu Kawaoka, Nobuhiko Hiraga, Shoichi Takahashi, Shintaro Takaki, Masataka Tsuge, Yuko Nagaoki, Yoshimasa Hashimoto, Yoshio Katamura, Daiki Miki, Akira Hiramatsu, Koji Waki, Michio Imamura, Yoshiiku Kawakami, Hiroshi Aikata, Hidenori Ochi, Hirotaka Tashiro, Hideki Ohdan & Kazuaki Chayama. (2012) Achievement of Sustained Viral Response after Switching Treatment from Pegylated Interferon a-2b to a-2a and Ribavirin in Patients with Recurrence of Hepatitis C Virus Genotype 1 Infection after Liver Transplantation: A Case Report. Intervirology 55:4, pages 122-126.
Crossref
S. Ciesek & H. Wedemeyer. (2011) Immunosuppression, liver injury and post‐transplant HCV recurrence. Journal of Viral Hepatitis 19:1, pages 1-8.
Crossref
T. Kawaoka, H. Aikata, S. Takaki, A. Hiramatsu, K. Waki, N. Hiraga, D. Miki, M. Tsuge, M. Imamura, Y. Kawakami, S. Takahashi, H. Ochi, H. Tashiro, H. Ohdan & K. Chayama. (2011) IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinoma. Journal of Viral Hepatitis 18:10, pages e550-e560.
Crossref
. (2011) Cyclosporine A-Based Immunosuppression Reduces Relapse Rate After Antiviral Therapy in Transplanted Patients With Hepatitis C Virus Infection: A Large Multicenter Cohort Study. Transplantation 92:3, pages 334-340.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.